According to a study published in the journal Cancer Cell, four research scientists from the Institute for Advanced Study and the Cancer Institute of New Jersey (CINJ) have identified a compound that may have the ability to correct a mutation and prevent the spreading of cancer. The study, as explained in a NJ.com news article, claims this development could eventually be used as treatment for tens of thousands of U.S. cancer patients per year.
The work conducted for this study involved a compound that fixes a mutation in the p53 protein, which is considered a type of “common denominator” in a variety of cancers, including pancreatic, esophageal, lung, breast, and ovarian cancer. The p53 protein, which is a form of intracellular security that typically prevents the spreading of malignant cells, is negated by cancer, allowing the spread of cancer cells. The compounds tested reactivated the p53 protein, which then would help prevent the spread of cancer cells. According to study investigators, the compounds slowed or shrank the growth of tumor cells in mice. This compound however is not necessarily a cure for cancer.
There is no miracle cancer drug. Effective treatment may involve knowing which drug combinations and dosages will be the most effective in eradicating cancer cell growth. Unfortunately, many healthcare providers fail to prescribe the most effective cancer treatment for their patients; or, cancers are not timely diagnosed; depriving a patient of a chance to have effective treatment.
If you have suffered as the result of a failed cancer diagnosis or a failure to prescribe correct or effective treatment, our New Jersey failure to diagnose cancer lawyers at Blume Forte can help you determine whether you may have a meritorious claim. To learn more, contact us at 973-845-4421.